| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,077 |
3,721 |
$144K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
963 |
732 |
$33K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
663 |
541 |
$19K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,209 |
899 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
641 |
435 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,085 |
915 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
133 |
100 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
187 |
140 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
1,678 |
1,279 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
254 |
203 |
$321.30 |
| 90686 |
|
35 |
28 |
$285.96 |
| 96127 |
|
36 |
28 |
$204.29 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
114 |
98 |
$161.69 |
| 96160 |
|
14 |
12 |
$153.08 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
465 |
371 |
$151.32 |
| 81003 |
|
148 |
115 |
$134.84 |
| 93000 |
|
16 |
12 |
$127.92 |
| 71046 |
Radiologic examination, chest; 2 views |
13 |
13 |
$123.17 |
| 92551 |
|
17 |
15 |
$110.35 |
| 81025 |
|
21 |
12 |
$71.40 |
| 3078F |
|
15 |
12 |
$0.01 |